Načítá se...
Mineralocorticoid Receptor Antagonist Treatment for Steroid-Induced Central Serous Chorioretinopathy Patients with Continuous Systemic Steroid Treatment
PURPOSE: To investigate the effectiveness of mineralocorticoid receptor (MR) antagonist in patients with steroid-induced central serous chorioretinopathy (CSC). METHODS: A retrospective review was conducted of steroid-induced CSC patients who were treated with the MR antagonist spironolactone 50 mg...
Uloženo v:
| Vydáno v: | J Ophthalmol |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Hindawi
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6081588/ https://ncbi.nlm.nih.gov/pubmed/30140452 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2018/4258763 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|